Founder of Ardea Biosciences, Inc. and Tang Capital Management LLC, Kevin C. Tang is a businessperson who has been at the helm of 6 different companies and holds the position of Chairman at La Jolla Pharmaceutical Co., Chairman & Chief Executive Officer of Odonate Therapeutics, Inc. and President for Tang Capital Management LLC.
He is also on the board of Tetraphase Pharmaceuticals, Inc. and Prospect Therapeutics, Inc.
In the past he held the position of Chairman of Heron Therapeutics, Inc., Director at Penwest Pharmaceuticals Co., Managing Director & Head-Life Sciences Research at Deutsche Bank Alex. Brown, Inc., Head of Life Sciences Research Group at Deutsche Bank Securities, Inc., Managing Director at Cash Reserve Fund, Inc., Director at IntraBiotics Pharmaceuticals, Inc. and Independent Director at Ardea Biosciences, Inc.
Kevin C. Tang received an undergraduate degree from Duke University.